Background And Objective: Cone-beam computed tomography (CBCT)-guided transbronchial biopsy (TBB) using an ultrathin bronchoscope (UTB) under virtual bronchoscopic navigation (VBN) is a useful method for diagnosing peripheral pulmonary lesions. A 1.2 mm working channel UTB (SC-UTB) and a 1.7 mm working channel UTB (LC-UTB) are available, with the latter allowing radial endobronchial ultrasound (R-EBUS). The aim of this study was to compare the diagnostic yield of CBCT-guided TBB under VBN using SC-UTB and LC-UTB with R-EBUS.
Methods: Patients with peripheral pulmonary lesions of ≤ 30 mm were included. Lesions with unidentifiable bronchi on CT scans were excluded. The UTB and biopsy forceps were advanced to the target bronchus under VBN and 2D-fluoroscopy. For cases using SC-UTB, CBCT was performed with forceps inserted. In cases using LC-UTB, CBCT was performed with forceps inserted after inserting the R-EBUS probe. The outcomes were compared between the two groups.
Results: SC-UTB was used in 89 patients, and LC-UTB with R-EBUS in 68 patients. The diagnostic yield was 64.0 % and 79.4 % in cases using SC-UTB and LC-UTB with R-EBUS, respectively, showing a significantly higher diagnostic yield with the latter (p = 0.036). Additionally, the proportion of type 1 images on the primary CBCT (forceps tip within the lesion) significantly increased (31.5 % vs. 50.0 %; p = 0.019), and the proportion of re-navigation after the primary CBCT decreased (47.5 % vs. 20.6 %; p = 0.001) in the LC-UTB with R-EBUS group.
Conclusion: In CBCT-guided TBB using UTB for peripheral pulmonary lesions, LC-UTB with R-EBUS demonstrated a higher diagnostic yield compared to SC-UTB. Conference presentation: none.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.lungcan.2025.108483 | DOI Listing |
Curr Opin Gastroenterol
March 2025
Academic Unit of Gastroenterology, Royal Hallamshire Hospital.
Purpose Of Review: Meckel's diverticulum (MD) is a common congenital ileal diverticulum. Whilst mostly asymptomatic, 4-9% develop complications, such as small bowel obstruction, diverticulitis or bleeding. In 1933, Charles Mayo wrote that MD is 'frequently suspected, often looked for and seldom found', and it continues to pose a diagnostic challenge today.
View Article and Find Full Text PDFEpileptic Disord
March 2025
Division of Child Neurology, Department of Pediatrics, Ege University Medical Faculty, Izmir, Turkey.
Objective: To evaluate the significance of genetic testing in neonatal- and infantile-onset genetic epilepsies (NIGEP) for enhanced molecular diagnosis with management implications.
Methods: A single-center cohort of 128 patients with NIGEP (aged 0-36 months) from 2010 to 2022 was retrospectively assessed. The diagnostic utility of genetic testing, including next-generation sequencing (NGS) and chromosome-based approaches, was surveyed to determine their impact on antiseizure medication adjustments and precision medicine.
Cells
February 2025
Department of Biological Sciences, University of New Hampshire, Durham, NH 03824, USA.
Typical investigations into the biological consequences of suspected xenobiotics or nutrients introduced in watersheds include analytical chemistry screens of environmental samples-such as periphyton responses or studies of fish condition-which are all costly in terms of equipment, reagents, time, and human resources. An alternative is to assess pollutant effects on waterborne bacteria. A flow cytometric method was developed to yield rapid, same-day results that could be used to proactively screen for suspected chemical inputs into watersheds using water sampling methods that are identical to those in standard use.
View Article and Find Full Text PDFJ Appl Lab Med
March 2025
Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Biomarker and Heart Failure Clinical Trials, Baim Institute for Clinical Research, Boston, MA, United States.
Background: N-terminal pro-B-type natriuretic peptide (NT-proBNP) measurement has class 1, level of evidence A recommendations in heart failure (HF) guidelines for diagnosis and prognosis. Analytical characterization of a novel automated NT-proBNP assay is necessary to examine its fitness for validation in pivotal clinical trials.
Methods: The Access NT-proBNP assay is an immunoenzymatic assay using monoclonal capture and detection reagents on the DxI 9000 Immunoassay Analyzer.
Eur J Immunol
March 2025
Core Facility for Cell Sorting and Cell Analysis, Rostock University Medical Center, Rostock, Germany.
Intracellular cytokine labeling combined with high-parametric flow cytometry offers substantial promise in elucidating the nuanced effector functions of cells. However, the establishment of complex multicolor panels is often laborious and the importance of validation processes may be underestimated in research practice. This raises the risk of prematurely translating multicolor panels into in vivo studies.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!